Related Experiment Video
Updated: Aug 9, 2026
15:09
The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
Published on: October 3, 2012
Familial Parkinson's disease. Alpha-synuclein and parkin
Y Mizuno1, N Hattori, T Kitada
1Department of Neurology, Juntendo University School of Medicine, Tokyo 113-8421, Japan.
Advances in Neurology
|September 14, 2001
Summary
Alpha-synuclein and parkin proteins are linked to Parkinson's disease (PD) neurodegeneration. Altered axonal transport of these presynaptic proteins may be crucial in PD pathogenesis.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Parkinson's disease (PD) involves nigral degeneration.
- Genetic mutations in alpha-synuclein and parkin are linked to familial PD.
- Autosomal dominant PD is associated with alpha-synuclein mutations (e.g., Ala53Thr, Ala30Pro).
- Autosomal recessive young-onset PD (ARJP) is linked to parkin mutations.
Purpose of the Study:
- To review the function of alpha-synuclein and parkin in PD.
- To understand their role in nigral degeneration in different PD inheritance patterns.
- To explore the link between axonal transport and PD pathogenesis.
Main Methods:
- Literature review of recent progress in PD research.
- Analysis of genetic mutations and protein functions.
- Examination of protein localization and cellular transport mechanisms.
Main Results:
- Alpha-synuclein mutations cause early-onset autosomal dominant PD.
- Parkin mutations cause autosomal recessive young-onset PD (ARJP).
- Both alpha-synuclein and parkin are associated with fast axonal transport.
- Normal alpha-synuclein self-aggregates in sporadic PD.
Conclusions:
- Altered axonal transport of presynaptic proteins is implicated in PD neurodegeneration.
- Understanding alpha-synuclein and parkin function is key to PD research.
- Defects in axonal transport may be a common pathway in various PD forms.
Related Concept Videos
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...